State Disclosures
Download PDF State Disclosures
Connecticut HB 6669
RoxyBond™ (Oxycodone Hydrochloride)
PROTEGA PHARMACEUTICALS provides the following information to Connecticut prescribers, as required by Connecticut House Bill 6669.
The pricing information below reflects PROTEGA PHARMACEUTICALS Wholesale Acquisition Costs (“WAC”) for their product: RoxyBond™ The WAC represents published catalogue or list price and may not represent actual transactional prices.
The price a customer pays may vary from the prices listed, depending, for example, on how the customer purchases the product, the availability of discounts, the wholesaler/distributor, or other charges.
WAC for RoxyBond™
| PRODUCT | NDC | DOSAGE FORM AND STRENGTH | WHOLESALE ACQUISITION COST (WAC) |
|---|---|---|---|
| RoxyBond | 81140-0101-10 | Tablet 5 MG | $1691.50 |
| RoxyBond | 81140-0102-10 | Tablet 15 MG | $2086.08 |
| RoxyBond | 81140-0103-10 | Tablet 30 MG | $2811.40 |
| RoxyBond | 81140-0104-10 | Tablet 10 MG | $1993.03 |
Generic versions of RoxyBond™ are currently available. Information on variation efficacy of the drug marketed to different racial and ethnic groups is not currently available. For more information on the price disclosure requirements, please contact the Connecticut State Board of Pharmacy at: State Board of Pharmacy 450 Columbus Blvd.
Hartford, CT 06103 Ph. (860) 713-6070 | Fax: (860) 706-1242 | Website: https://portal.ct.gov/DCP/Drug-Control-Division/Commission-of-Pharmacy/The-Commission-of-Pharmacy
Copyright© 2025 PROTEGA PHARMACEUTICALS All rights reserved. 10/9/2026